CompoAtlas

C-1000 + BIOFLAVONOIDS & ROSEHIP

Food supplement declared in France, declaration No 2022-3-266, decision dated 15 May 2025

C-1000 + BIOFLAVONOIDS & ROSEHIP (HSN) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
HSN
Food business operator placing the product on the market
HARRISON SPORT NUTRITION, S.L.
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Comprimé
Daily dose
1 comprimé
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous traitement antihypertenseur
Objectives stated by the manufacturer (these are not authorised claims)
Antioxydant

Declaration 174118, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Citrus aurantium L.FruitExtrait sec hydroalcoolique50 mg
Rosa canina L.Faux fruitPoudre (de plantes séchées ou broyées)20 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg

Additives

E460, E464, E463, E468, E470b, E551

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Le produit est déconseillé aux enfants, aux femmes enceintes ou allaitantes et aux personnes suivant un traitement antihypertenseur.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : HSN

Enter to analyse, Shift+Enter for a new line